Personal Genome Diagnostics' CancerSelect Targeted Gene Panel
Nov 17, 2014
Personal Genome Diagnostics has launched its CancerSelect targeted gene panel through its MyPersonalGenome service. The CancerSelect panel detects alterations in 88 well-characterized genes that include all targets of currently available or investigational cancer treatment options, the firm said. PGDx analyzes the CancerSelect genes using next-generation sequencing at extremely high coverage and proprietary PGDx technologies to identify a comprehensive list of genetic alterations, including point mutations, copy number alterations, and genetic rearrangements.